Theravance Biopharma, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of TBPH for the last quarter is 17.57 M USD, and it's 11.93% higher compared to the previous quarter. The net income of Q4 23 is -8.51 M USD.